NEW YORK, Aug. 8, 2019 /PRNewswire/ -- WeissLaw LLP is
investigating possible breaches of fiduciary duty and other
violations of law by the Board of Directors of Corindus Vascular
Robotics, Inc. ("Corindus" or the "Company") (NYSE: CVRS) in
connection with the proposed acquisition of the Company by a
subsidiary of Siemens Healthineers AG ("Siemens
Healthineers"). Under the terms of the agreement, Corindus
shareholders will receive $4.28 per
CVRS share.
If you own CVRS shares and wish to discuss
this investigation or have any questions concerning this notice or
your rights or interests, please contact:
Joshua Rubin,
Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
stockinfo@weisslawllp.com
Visit our website
http://www.weisslawllp.com/corindus-vascular-robotics-inc/
Or follow us on Twitter @MarketsAlert
WeissLaw is investigating whether Corindus's
Board acted to maximize shareholder value prior to entering
into the acquisition agreement. According to the acquisition
announcement, Siemens Healthineers hopes to use the Company's
established position in vascular robotics and strong technology
platform in robotic-assisted procedures to drive its own growth in
the vascular robotics industry.
Given these facts, WeissLaw is concentrating its investigation
on whether the acquisition enhances shareholder value.
WeissLaw is also concerned whether the proposed acquisition
undervalues the Company, and whether all material information
related to the proposed acquisition is fully and fairly
disclosed.
WeissLaw LLP has litigated hundreds of stockholder class and
derivative actions for violations of corporate and fiduciary
duties. We have recovered over a billion dollars for
defrauded clients and obtained important corporate governance
relief in many of these cases. If you have information or
would like legal advice concerning possible corporate wrongdoing
(including insider trading, waste of corporate assets, accounting
fraud, or materially misleading information), consumer fraud
(including false advertising, defective products, or other
deceptive business practices), or anti-trust violations, please
email us at stockinfo@weisslawllp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-corindus-vascular-robotics-inc-300899116.html
SOURCE WeissLaw LLP